SUMMARY
Our experience with thromboembolism in 283 patients surviving at least 1 week following insertion of Starr-Edwards valves is reported here. Of these patients, 155 underwent aortic valve replacement, 21 had aortic valve replacement with mitral commissurotomy, 80 had mitral replacement, and 27 had both aortic and mitral valve replacement. Complete follow-up data were obtained on all patients, from 3 to 49 months following surgery (mean, 20 months).
Thromboembolic episodes developed in 68 of the 283 patients (24%). Seventeen of these 68 patients died (25%), three had serious neurological residual (4%), but the majority of survivors recovered completely.
Use of long-term anticoagulant therapy appeared to reduce incidence of embolic episodes only in patients with aortic valve replacement. Control Of paramount importance in determining the incidence of systemic embolization in a study such as this is adequacy of follow-up and care taken to detect all instances of embolism. In the present series, we were able to account for almost 100% of the patients entering with aortic or mitral prostheses, and in patients of Duvoisin and associates5 with mitral prostheses.
The central nervous system was the common site involved by thromboembolism, in agreement with the finding of other groups. 5' 8 Of interest is the fact that coronary artery embolism, an uncommon cause of myocardial infarction, has been reported in a number of patients with prosthetic valves.10 11 Thromboembolism was responsible for 17 deaths (25% of those who had emboli). Although 4% of patients with thromboembolism were left with severe residual defects and 21% had mild impairment of function, 50% recovered completely. The disputed efficacy of anticoagulants in preventing embolic complications has stimulated sustained interest in improved prosthesis design. Preliminary follow-up of patients with the newer model Starr-Edwards prostheses (no. 1200 aortic valve, no. 6120 mitral valve) suggests that embolism may be much less of a problem12 (and Starr, personal communication). The present study can serve as a basis for comparison with valve prosthesis of improved design in the future.
